VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. Am J Hematol. 2021 05 01; 96(5):E137-E140.
View in:
PubMed
subject areas
Antineoplastic Agents
Benzamides
Combined Modality Therapy
Disease Progression
Drug Substitution
Follow-Up Studies
Humans
Immunotherapy, Adoptive
Kaplan-Meier Estimate
Lymphoma, Mantle-Cell
Mutation
Protein Kinase Inhibitors
Pyrazines
Recurrence
Salvage Therapy
Sample Size
Treatment Outcome
Withholding Treatment
authors with profiles
LORETTA NASTOUPIL
CHI YOUNG OK